Morgan Lewis partner Keith Gottfried was interviewed for an Agenda article about boards electing to move to poison pills in response to the coronavirus (COVID-19) pandemic. “Any company that has had its market cap substantially shrunken by 50% or more from a 52-week high, which is not a small number of companies, would do well to at the very least have a pill on the shelf,” said Keith. “Have all the work done for a pill, completely vetted, comfortable and ready to go with less than 48 hours to pull the trigger.”
Read the full Agenda article >>
Subscription may be required.